RecruitingEarly Phase 1NCT06628154

Losartan and Emotional Learning

The Effects of Single-dose Losartan on Cognitive Flexibility and Learning in Healthy Adults: a Randomised Controlled Study


Sponsor

University of Oxford

Enrollment

60 participants

Start Date

Aug 14, 2024

Study Type

INTERVENTIONAL

Conditions

Summary

This study explores the effects of single-dose losartan (50mg) versus placebo on emotional processing in healthy volunteers.


Eligibility

Min Age: 18 YearsMax Age: 50 Years

Plain Language Summary

Simplified for easier understanding

This study examines whether a blood pressure drug called losartan affects emotional learning and memory — specifically how people learn and unlearn fear or reward associations. Losartan blocks a hormone called angiotensin II, which may influence memory circuits in the brain. **You may be eligible if...** - You are between 18 and 50 years old - You have low to moderate anhedonia (reduced ability to feel pleasure, assessed by questionnaire) - You speak and read English well enough to complete the study tasks - You are a non-smoker or light smoker (fewer than 5 cigarettes per day) **You may NOT be eligible if...** - You have (or have had) a psychiatric diagnosis other than anxiety, dysthymia, or unipolar depression - You have taken any CNS medications in the past 6 weeks - You are currently on blood pressure medication, especially aliskiren or beta-blockers - You have a first-degree family member with severe psychiatric illness Talk to your doctor to see if this trial is right for you.

This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.

Interested in this trial?

Get notified about updates and connect with the research team.

Interventions

DRUGLosartan potassium 50mg

Single dose losartan (50 mg, weight-adjusted), encapsulated identically to placebo

OTHERPlacebo

Single tablet encapsulated identically to losartan


Locations(1)

Warneford Hospital, University of Oxford

Oxford, Oxfordshire, United Kingdom

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT06628154


Related Trials